Left ventricular (LV) segmental wall motion abnormality (SWMA) refers to a localized impairment in the contractile function of a specific segment of the left ventricle. This abnormality is characterized by a decrease or absence of normal systolic wall thickening and movement, resulting in impaired ejection of blood from the heart. The underlying causes are diverse, ranging from coronary artery disease to non-ischemic cardiomyopathies. Understanding the etiology, diagnosis, and management of LV SWMA is crucial for optimizing patient outcomes. This article will delve into the various aspects of this condition, drawing upon established medical knowledge and research.
Sol Ventrikül Segmenter Duvar Hareket Bozukluğuna Neden (Causes of LV Segmental Wall Motion Abnormality):
The most common cause of LV SWMA is ischemic heart disease (IHD), specifically coronary artery disease (CAD). CAD leads to reduced blood flow to a portion of the myocardium, causing myocardial ischemia and potentially infarction. This inadequate perfusion results in a compromised ability of the affected myocardial segment to contract effectively. The severity of the wall motion abnormality directly correlates with the extent and duration of ischemia. A complete occlusion of a coronary artery will typically lead to a more severe akinesia (absence of movement) or dyskinesia (abnormal movement) compared to a partial occlusion which might present as hypokinesia (reduced movement).
The provided Turkish text states: "Buna bağlı olarak bu arterin beslediği duvarda perfuzyon bozukluğu ve beslenemeyen segmentte duvar hareket kusuru ortaya çıkar. Ortaya çıkan kasılma kusurunu tolere etmek için sıklıkla karşı duvarda da akut…" This translates to: "Consequently, perfusion disorder occurs in the wall supplied by this artery, and a wall motion defect appears in the unperfused segment. To tolerate the resulting contraction defect, acute…" This highlights the direct link between coronary artery blockage, impaired perfusion (blood flow), and the subsequent development of LV SWMA. The “…akut…” suggests a compensatory mechanism, possibly referring to acute remodeling or changes in the opposing wall to compensate for the impaired segment. This compensatory mechanism, while initially helpful, can eventually contribute to further cardiac dysfunction.
Beyond CAD, several other factors can contribute to LV SWMA:
* Non-ischemic cardiomyopathies: These conditions affect the heart muscle itself, leading to impaired contractility independent of coronary artery blockage. Examples include dilated cardiomyopathy, hypertrophic cardiomyopathy, and restrictive cardiomyopathy. These conditions often present with diffuse or more widespread wall motion abnormalities, but segmental involvement can also occur.
* Myocarditis: Inflammation of the heart muscle can cause regional dysfunction. Viral infections are a common cause of myocarditis.
* Valvular heart disease: Severe valvular stenosis or regurgitation can place excessive strain on the left ventricle, leading to regional wall motion abnormalities. Aortic stenosis, for example, can cause hypertrophy and dysfunction of the left ventricular septum.
* Cardiac tumors: Tumors within the heart can directly obstruct blood flow or compress the myocardium, resulting in segmental wall motion abnormalities.
* Congenital heart defects: Certain congenital heart defects can lead to abnormal LV geometry and function, contributing to SWMA.
* Drug toxicity: Some medications can have cardiotoxic effects, leading to myocardial dysfunction and SWMA.
* Valve dysfunction: Problems with the mitral or aortic valves can alter ventricular loading and result in abnormal wall motion.
current url：https://gdaszd.e513c.com/blog/lv-segmenter-duvar-hareket-bozuklu%C4%9Fu-42317